Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23821)

• Formulation Name: Mirabegron 50mg extended release tablet
• Company: Apgdi

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Mirabegron	(DMS1GYT)	Overactive bladder	GC50.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Hydroxypropyl cellulose	(E00632)	Not Available	Binding agent; Coating agent; Emulsifying agent; Film/Membrane-forming agent; Modified-release agent; Suspending agent; Viscosity-controlling agent
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 4000	(E00654)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant